GlycoNet Researchers identify a possible target in the prevention and treatment of bacterial infections.
Category: Research Highlight
GlycoNet researchers develop hybrid enzyme to unlock the potential of enzyme replacement therapy
Keeping the gut microbiota, the micro-organisms living in our intestines, in balance is important in preventing disease.A GlycoNet-funded project is looking at using glycans (sugars) to restore an imbalance that occurs in patients suffering from inflammatory bowel disease (IBD).
The power and promise of carbohydrate moleculesFor anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms. More stubborn stones can require surgery.GlycoNet-funded research is testing the safety and efficacy of a glycoside, called arbutin, which is extracted from the bearberry plant. The molecule has shown a remarkable ability to break up kidney stones in pre-clinical studies.